[1]曾书燚,王正东,陈 坚,等.药物洗脱球囊与药物洗脱支架治疗支架内再狭窄疗效比较 [J].介入放射学杂志,2017,(09):839-842.
 ZENG Shuyi,WANG Zhengdong,CHEN Jian,et al.Paclitaxel- eluting balloon versus drug- eluting stent for in- stent restenosis: comparative study of curative effect[J].journal interventional radiology,2017,(09):839-842.
点击复制

药物洗脱球囊与药物洗脱支架治疗支架内再狭窄疗效比较 

()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2017年09期
页码:
839-842
栏目:
临床研究
出版日期:
2017-09-25

文章信息/Info

Title:
Paclitaxel- eluting balloon versus drug- eluting stent for in- stent restenosis: comparative study of curative effect
作者:
曾书燚 王正东 陈 坚 李 平 谢文超 林智海 黎艺毅
Author(s):
ZENG Shuyi WANG Zhengdong CHEN Jian LI Ping XIE Wenchao LIN Zhihai LI Yiyi
Department of Cardiovascular Medicine, Yulin Municipal First People’s Hospital, Yulin, Guangxi Province 537000, China
关键词:
【关键词】 药物洗脱球囊 药物洗脱支架 支架内再狭窄 安全性 有效性
文献标志码:
A
摘要:
【摘要】 目的 对比药物洗脱球囊(DEB)和药物洗脱支架(DES)治疗冠状动脉疾病支架植入后支架内再狭窄(ISR)的安全性和有效性。方法 回顾性分析2012 年1月至 2014 年12月收治的76例支架植入后ISR患者临床资料。根据治疗方法分为紫杉醇DEB组(n=32)和紫杉醇DES组(n=44)。收集一般资料及冠状动脉造影特征,记录术后1年患者全因死亡、心源性死亡、心肌梗死、支架内血栓形成、靶病变血运重建、靶血管血运重建、主要心血管不良事件(MACE)。结果 DEB组和DES组患者一般资料具有良好均衡性(P>0.05)。ISR发生在前降支较多(DEB组43.75%,DES组47.73%)。两组ISR靶血管类型类似(P>0.05)。两组裸金属支架(BMS)和DES植入术后ISR类型、ISR病变类型、再狭窄支架特点差异均无统计学意义(P>0.05)。随访12个月显示,全因死亡、心源性死亡、心肌梗死、支架内血栓形成、靶血管血运重建、靶病变血运重建及MACE发生率差异均无统计学意义(P>0.05)。进一步分析无事件生存率,两组差异无统计学意义(P>0.05)。结论 DEB治疗BMS或DES植入术后ISR安全可行,疗效不低于DES治疗。

参考文献/References:

[1] Mamuti W, Jiamali A, Rao F, et al. Drug- coated balloon angioplasty for drug- eluting stent restenosis: insight from randomized controlled trials[J]. Ann Med, 2014, 46: 679- 683.
[2] Fischer D, Scheller B, Sch?覿fer A, et al. Paclitaxcel- coated balloon plus bare metal stent vs. sirolimus- eluting stent in de novo lesions: an IVUS study[J]. EuroIntervention, 2012, 8: 450- 455.
[3] Alfonso F, Perez- Vizcayno MJ, Cardenas A, et al. A prospective randomized trial of drug- eluting balloons versus everolimus- eluting stents in patients with in- stent restenosis of drug- eluting stents: the RIBS Ⅳ randomized clinical trial[J]. J Am Coll Cardiol, 2015, 66: 23- 33.
[4] 杨 娜, 赵学忠, 王全伟, 等. 冠状动脉支架内再狭窄的研究进展[J]. 中国老年学杂志, 2014, 34: 1731- 1733.
[5] Rekhter MD, O’brien E, Shah N, et al. The importance of thrombus organization and stellate cell phenotype in collagen Ⅰ gene expression in human, coronary atherosclerotic and restenotic lesions[J]. Cardiovasc Res, 1996, 32: 496- 502.
[6] Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy[J]. Circ J, 2011, 75: 1287- 1296.
[7] Drachman DE, Simon DI. Inflammation as a mechanism and therapeutic target for in- stent restenosis[J]. Curr Atheroscler Rep, 2005, 7: 44- 49.
[8] 张文俐, 杜 润, 朱政斌, 等. 药物洗脱球囊抑制下肢动脉狭窄性病变的实验研究[J]. 介入放射学杂志, 2014, 23: 423- 426.
[9] Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis[J]. Circulation, 2004, 110: 810- 814.
[10] Rittger H, Brachmann J, Sinha AM, et al. A randomized, multicenter, single- blinded trial comparing paclitaxel- coated balloon angioplasty with plain balloon angioplasty in drug- eluting stent restenosis: the PEPCAD- DES study[J]. J Am Coll Cardiol, 2012, 59: 1377- 1382.
[11] Byrne RA, Neumann FJ, Mehilli J, et al. Paclitaxel- eluting balloons, paclitaxel- eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug- eluting stent (ISAR- DESIRE 3): a randomised, open- label trial[J]. Lancet, 2013, 381: 461- 467.
[12] Xu B, Gao R, Wang J, et al. A prospective, multicenter, randomized trial of paclitaxel- coated balloon versus paclitaxel- eluting stent for the treatment of drug- eluting stent in- stent restenosis: results from the PEPCAD China ISR trial[J]. JACC Cardiovasc Interv, 2014, 7: 204- 211.
[13] Habara S, Kadota K, Kanazawa T, et al. Paclitaxel- coated balloon catheter compared with drug- eluting stent for drug- eluting stent restenosis in routine clinical practice[J]. EuroIntervention, 2016, 11: 1098- 1105.
[14] 崔孔勇, 吕树铮, 柳 弘, 等. 紫杉醇药物洗脱球囊与西罗莫司药物洗脱支架治疗再狭窄的比较[J]. 心肺血管病杂志, 2016, 35: 499- 504.

相似文献/References:

[1]苏 胜,邱 宁,张 红,等. 糖尿病对老年冠状动脉慢性完全闭塞患者经皮介入治疗后的影响[J].介入放射学杂志,2013,(09):714.
 SU Sheng,QIU Ning,ZHANG Hong,et al. Influence of diabetes mellitus on the prognosis of chronic total coronary occlusion in aged patients after percutaneous coronary intervention[J].journal interventional radiology,2013,(09):714.
[2]欧阳墉,欧阳雪晖,张学军,等. 新一代药物洗脱支架及其抗血栓形成的作用[J].介入放射学杂志,2014,(05):369.
 OUYANG Yong,OUYANG Xue- hui,ZHANG Xue- jun,et al. The new generation drug- eluting stents and their effects of anti- thrombosis [J].journal interventional radiology,2014,(09):369.
[3]张文俐,朱政斌,杜 润,等.急性心肌梗死患者药物洗脱支架植入后光学相干层析成像研究[J].介入放射学杂志,2015,(04):287.
 ZHANG Wen li,ZHU Zheng bin,DU Run,et al.Assessment of vascular healing with optical coherence tomography in patients with acute myocardial infarction after receiving drug eluting stent implantation[J].journal interventional radiology,2015,(09):287.
[4]潘春仰,邱建平,陆 林,等.冠状动脉介入治疗后支架内再狭窄相关因素[J].介入放射学杂志,2015,(06):467.
 PAN Chun-yang,QIU Jian-ping,LU Lin,et al.Investigation of factors related to the occurrence of in-stent restenosis after percutaneous coronary intervention[J].journal interventional radiology,2015,(09):467.
[5]钟继明,黄学成,张景昌,等.冠状动脉雷帕霉素涂层支架植入术后支架内再狭窄临床预测因素探讨 [J].介入放射学杂志,2017,(10):874.
 ZHONG Jiming,HUANG Xuecheng,ZHANG Jingchang,et al.Investigation of the clinical predictors of in- stent restenosis after rapamycin- eluting coronary stent implantation[J].journal interventional radiology,2017,(09):874.
[6]李锦爽,王万虹,周 浩,等.药物洗脱球囊治疗糖尿病伴复杂冠状动脉病变的临床效果[J].介入放射学杂志,2019,28(08):770.
 LI Jinshuang,WANG Wanhong,ZHOU Hao,et al.Drug- eluting balloon for the treatment of complex coronary artery disease associated with diabetes mellitus: analysis of curative effect[J].journal interventional radiology,2019,28(09):770.
[7]黄志志,廖 宝,梁 柯,等.国产雷帕霉素洗脱支架治疗椎动脉狭窄临床研究[J].介入放射学杂志,2020,29(11):1072.
 HUANG Zhizhi,LIAO Bao,LIANG Ke,et al.Domestic rapamycin-eluting stent for the treatment of vertebral artery stenosis: a clinical study[J].journal interventional radiology,2020,29(09):1072.
[8]唐超坤,齐 立,周 维,等.药物洗脱支架与金属裸支架治疗颅内动脉狭窄比较[J].介入放射学杂志,2022,31(11):1052.
 TANG Chaokun,QI Li,ZHOU Wei,et al.Drug-eluting stent versus bare metal stent in the treatment of intracranial artery stenosis[J].journal interventional radiology,2022,31(09):1052.

备注/Memo

备注/Memo:
(收稿日期:2016-10-10)
(本文编辑:边 佶)
更新日期/Last Update: 2017-09-12